Nicolas Biz, CDMO chief project officer, shows how Seqens rapidly developed production of a key material in the fight against Covid-19

Dow’s headquarters site at Midland, Michigan, was hit by flooding on the morning of 20 May following the collapse of two dams.

DSM, Bayer, Symrise, Henkel and Takasago International are among 155 companies signing a joint release by the Science Based Targets initiative (SBTi), the UN Global Compact, and the We Mean Business coalition.

Clariant is expanding its capabilities for the Hostapon SCI brand of isethionate derivatives at its site in Mount Holly, US, and Tarragona, Spain. This will comprise both capacity increases and modernisation via optimised energy consumption and aggregate options for new SI grades.

Mark Quick, EVP of  corporate development at Recipharm, discusses the M&A trend within the CDMO industry

Six days after the US and the UK began formal negotiations for a post-Brexit bilateral trade deal on 5 May, representatives from the respective industry associations, the American Chemistry Council (ACC) and the Chemical Industries Association (CIA) jointly published some comments outlining their

Several of the world’s major pharmaceutical CDMOS have recently made announcements relating to their participation in projects to develop treatment for the Covid-19 virus. Many involve chloroquines, in anticipation of their large-scale use.

Skin care giant Beiersdorf and Evonik have agreed a research partnership to develop sustainable raw materials for personal care products via artificial photosynthesis, using CO₂ as the starting material, along with water, solar energy and bacteria.

Bachem, the world’s largest producer of pharmaceutical peptides and ologonucleotides, has signed an exclusive licensing agreement with Japanese firm Jitsubo related to the latter’s liquid-phase peptide technology. Molecular Hiving. Financial terms were not disclosed.